Detalhe da pesquisa
1.
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study.
Lancet Reg Health Eur
; 41: 100912, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38665620
2.
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912].
Lancet Reg Health Eur
; 42: 100940, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38813536
3.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Eur J Cancer
; 202: 114006, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38489861